SEC Form D · Amendment · filed December 5, 2018
Akeso Biomedical, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (21)
Mark C. Wagstaff · Fayetteville, ARExecR. C. Goforth · Fayetteville, ARDirectorSimon W. Williams · Waltham, MAExec · DirectorKevin C. Ohashi · Fayetteville, ARDirectorGreg W. Lee · Fayetteville, ARDirectorScott W. Roth · Waltham, MADirectorAnthony W. Sinskey · Boston, MADirectorAjit Rajasekharan · Cambridge, MAExecPreston Dishner · Knoxville, TNDirectorRichard A. Martin · Lubbock, TXExec · DirectorIan Lokkerbol · London, United KingdomDirectorDavid Goel · Cambridge, MADirectorJohn Gustofson · Greenville, NCDirectorWilliam E. Diamond · Mt Kisco, NYDirectorMichael K. Schilling · Nikiski, AKExec · DirectorScott Epstein · New York, NYDirectorEyal A. Lalo · EDEN PRAIRIE, MNDirectorCarl E. Ring, Jr · MORRISTOWN, NJDirectorBruce Flitcroft · MORRISTOWN, NJDirectorVictoria Treyger · Menlo Park, CADirectorSundeep Peechu · Menlo Park, CAExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗